Astellas Pharma US, Inc. drugs
11 results
Astagraf xl (tacrolimus extended-release capsules)
(tacrolimus extended-release capsules)Astellas Pharma US, Inc.
Usage: ASTAGRAF XL® is indicated for the prevention of organ rejection in kidney transplant patients, used alongside other immunosuppressants for both adult and pediatric patients who can swallow capsules intact.
Cresemba (isavuconazonium sulfate)
(isavuconazonium sulfate)Astellas Pharma US, Inc.
Usage: CRESEMBA is indicated for the treatment of invasive aspergillosis and invasive mucormycosis in adults and pediatric patients, with different age and weight requirements for injection and capsule formulations. Prior laboratory tests to identify the causative organisms should be conducted before starting therapy.
Izervay (avacincaptad pegol)
(avacincaptad pegol)Astellas Pharma US, Inc.
Usage: IZERVAY™ is indicated for the treatment of geographic atrophy (GA) associated with age-related macular degeneration (AMD).
Lexiscan (regadenoson)
(regadenoson)Astellas Pharma US, Inc.
Usage: LEXISCAN® (regadenoson) injection is indicated as a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients who cannot perform adequate exercise stress.
Mycamine (micafungin sodium)
(Micafungin sodium)Astellas Pharma US, Inc.
Usage: MYCAMINE® is indicated for treating candidemia, acute disseminated candidiasis, Candida peritonitis, and esophageal candidiasis in patients 4 months and older. It is also used for prophylaxis of Candida infections in patients undergoing hematopoietic stem cell transplantation. Use in pediatric patients under 4 months has limitations.
Myrbetriq (mirabegron)
(mirabegron)Astellas Pharma US, Inc.
Usage: MYRBETRIQ is indicated for the treatment of overactive bladder (OAB) in adults, addressing symptoms of urge urinary incontinence, urgency, and urinary frequency. It is also used in pediatric patients aged 3 and older for neurogenic detrusor overactivity (NDO), specifically in those weighing 35 kg or more.
Prograf (tacrolimus)
(Tacrolimus)Astellas Pharma US, Inc.
Usage: PROGRAF® is indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic transplants of the kidney, liver, heart, or lung, as part of a regimen with other immunosuppressants.
Veozah (fezolinetant)
(fezolinetant)Astellas Pharma US, Inc.
Usage: VEOZAH® is indicated for treating moderate to severe vasomotor symptoms associated with menopause.
Vyloy (zolbetuximab)
(ZOLBETUXIMAB)Astellas Pharma US, Inc.
Usage: VYLOY is indicated for the first-line treatment of adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma, specifically for those with claudin 18.2 positive tumors, in combination with fluoropyrimidine- and platinum-containing chemotherapy.
Xospata (gilteritinib)
(gilteritinib)Astellas Pharma US, Inc.
Usage: XOSPATA is indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) who have a FMS-like tyrosine kinase 3 (FLT3) mutation, as confirmed by an FDA-approved test.